Literature DB >> 18202196

Morphological and functional features of hepatic cyst epithelium in autosomal dominant polycystic kidney disease.

Domenico Alvaro1, Paolo Onori, Gianfranco Alpini, Antonio Franchitto, Douglas M Jefferson, Alessia Torrice, Vincenzo Cardinale, Fabrizio Stefanelli, Maria Grazia Mancino, Mario Strazzabosco, Mario Angelico, Adolfo Attili, Eugenio Gaudio.   

Abstract

We evaluated the morphological and functional features of hepatic cyst epithelium in adult autosomal dominant polycystic kidney disease (ADPKD). In six ADPKD patients, we investigated the morphology of cyst epithelium apical surface by scanning electron microscopy and the expression of estrogen receptors (ERs), insulin-like growth factor 1 (IGF1), IGF1 receptors (IGF1-R), growth hormone receptor, the proliferation marker proliferating cell nuclear antigen, and pAKT by immunohistochemistry and immunofluorescence. Proliferation of liver cyst-derived epithelial cells was evaluated by both MTS proliferation assay and [(3)H]thymidine incorporation into DNA. The hepatic cyst epithelium displayed heterogeneous features, being normal in small cysts (<1 cm), characterized by rare or shortened cilia in 1- to 3-cm cysts, and exhibiting the absence of both primary cilia and microvilli in large cysts (>3 cm). Cyst epithelium showed marked immunohistochemical expression of ER, growth hormone receptor, IGF1, IGF1-R, proliferating cell nuclear antigen, and pAKT. IGF1 was 10-fold more enriched in the hepatic cyst fluid than in serum. Serum-deprived liver cyst-derived epithelial cells proliferated when exposed to 17beta-estradiol and IGF1 and when exposed to human cyst fluid. ER or IGF1-R antagonists inhibited the proliferative effect of serum readmission, cyst fluid, 17beta-estradiol, and IGF1. Our findings could explain the role of estrogens in accelerating the progression of ADPKD and may suggest a potential benefit of therapeutic strategies based on estrogen antagonism.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18202196      PMCID: PMC2312356          DOI: 10.2353/ajpath.2008.070293

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  50 in total

1.  Genetic evidence for a trans-heterozygous model for cystogenesis in autosomal dominant polycystic kidney disease.

Authors:  M Koptides; R Mean; K Demetriou; A Pierides; C C Deltas
Journal:  Hum Mol Genet       Date:  2000-02-12       Impact factor: 6.150

2.  Effects of angiogenic factor overexpression by human and rodent cholangiocytes in polycystic liver diseases.

Authors:  Luca Fabris; Massimiliano Cadamuro; Romina Fiorotto; Tania Roskams; Carlo Spirlì; Saida Melero; Aurelio Sonzogni; Ruth E Joplin; Lajos Okolicsanyi; Mario Strazzabosco
Journal:  Hepatology       Date:  2006-05       Impact factor: 17.425

3.  Estrogens and insulin-like growth factor 1 modulate neoplastic cell growth in human cholangiocarcinoma.

Authors:  Domenico Alvaro; Barbara Barbaro; Antonio Franchitto; Paolo Onori; Shannon S Glaser; Gianfranco Alpini; Heather Francis; Luca Marucci; Paola Sterpetti; Stefano Ginanni-Corradini; Andrea Onetti Muda; David E Dostal; Adriano De Santis; Adolfo F Attili; Antonio Benedetti; Eugenio Gaudio
Journal:  Am J Pathol       Date:  2006-09       Impact factor: 4.307

Review 4.  New advances in evaluation and management of patients with polycystic liver disease.

Authors:  Hays L Arnold; Stephen A Harrison
Journal:  Am J Gastroenterol       Date:  2005-11       Impact factor: 10.864

Review 5.  Proliferating cholangiocytes: a neuroendocrine compartment in the diseased liver.

Authors:  Domenico Alvaro; Maria Grazia Mancino; Shannon Glaser; Eugenio Gaudio; Marco Marzioni; Heather Francis; Gianfranco Alpini
Journal:  Gastroenterology       Date:  2006-07-24       Impact factor: 22.682

6.  Cholangiocyte cilia detect changes in luminal fluid flow and transmit them into intracellular Ca2+ and cAMP signaling.

Authors:  Anatoliy I Masyuk; Tatyana V Masyuk; Patrick L Splinter; Bing Q Huang; Angela J Stroope; Nicholas F LaRusso
Journal:  Gastroenterology       Date:  2006-09       Impact factor: 22.682

7.  Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3',5'-cyclic monophosphate.

Authors:  Tatyana V Masyuk; Anatoliy I Masyuk; Vicente E Torres; Peter C Harris; Nicholas F Larusso
Journal:  Gastroenterology       Date:  2006-12-20       Impact factor: 22.682

8.  Activation of vascular endothelial growth factor (VEGF) by the ER-alpha variant, ERDelta3.

Authors:  Sailaja Koduri; Anita S Goldhar; Barbara K Vonderhaar
Journal:  Breast Cancer Res Treat       Date:  2006-01       Impact factor: 4.872

9.  Activation of the IGF1 system characterizes cholangiocyte survival during progression of primary biliary cirrhosis.

Authors:  Paolo Onori; Domenico Alvaro; Anna Rosa Floreani; Maria Grazia Mancino; Antonio Franchitto; Maria Guido; Guido Carpino; Adriano De Santis; Mario Angelico; Adolfo F Attili; Eugenio Gaudio
Journal:  J Histochem Cytochem       Date:  2006-12-12       Impact factor: 2.479

10.  The antioxidant effect of estrogen and Selective Estrogen Receptor Modulators in the inhibition of osteocyte apoptosis in vitro.

Authors:  Val Mann; Christene Huber; Giolanta Kogianni; Frances Collins; Brendon Noble
Journal:  Bone       Date:  2006-12-13       Impact factor: 4.398

View more
  33 in total

Review 1.  Autosomal dominant polycystic kidney disease: the last 3 years.

Authors:  Vicente E Torres; Peter C Harris
Journal:  Kidney Int       Date:  2009-05-20       Impact factor: 10.612

2.  Liver Failure in Advanced Adult-onset Polycystic Kidney Disease.

Authors:  Christina Awad; Grant Gardner Gallimore
Journal:  BMJ Case Rep       Date:  2018-04-13

3.  Taurocholate feeding to bile duct ligated rats prevents caffeic acid-induced bile duct damage by changes in cholangiocyte VEGF expression.

Authors:  Romina Mancinelli; Paolo Onori; Eugenio Gaudio; Antonio Franchitto; Guido Carpino; Yoshiyuki Ueno; Domenico Alvaro; Luigi P Annarale; Sharon Demorrow; Heather Francis
Journal:  Exp Biol Med (Maywood)       Date:  2009-02-20

4.  Inhibition of metalloprotease hyperactivity in cystic cholangiocytes halts the development of polycystic liver diseases.

Authors:  Aura D Urribarri; Patricia Munoz-Garrido; María J Perugorria; Oihane Erice; Maite Merino-Azpitarte; Ander Arbelaiz; Elisa Lozano; Elizabeth Hijona; Raúl Jiménez-Agüero; Maite G Fernandez-Barrena; Juan P Jimeno; Marco Marzioni; Jose J G Marin; Tatyana V Masyuk; Nicholas F LaRusso; Jesús Prieto; Luis Bujanda; Jesús M Banales
Journal:  Gut       Date:  2014-01-16       Impact factor: 23.059

5.  HDAC6 is overexpressed in cystic cholangiocytes and its inhibition reduces cystogenesis.

Authors:  Sergio A Gradilone; Stefan Habringer; Tatyana V Masyuk; Brynn N Howard; Anatoliy I Masyuk; Nicholas F Larusso
Journal:  Am J Pathol       Date:  2014-01-13       Impact factor: 4.307

Review 6.  Therapeutic Targets in Polycystic Liver Disease.

Authors:  Tatyana V Masyuk; Anatoliy I Masyuk; Nicholas F LaRusso
Journal:  Curr Drug Targets       Date:  2017       Impact factor: 3.465

7.  Vasopressin regulates the growth of the biliary epithelium in polycystic liver disease.

Authors:  Romina Mancinelli; Antonio Franchitto; Shannon Glaser; Antonella Vetuschi; Julie Venter; Roberta Sferra; Luigi Pannarale; Francesca Olivero; Guido Carpino; Gianfranco Alpini; Paolo Onori; Eugenio Gaudio
Journal:  Lab Invest       Date:  2016-08-29       Impact factor: 5.662

8.  Expression and localization of growth hormone receptor in the oviduct of cyclic and pregnant pigs and mid-implantation conceptuses.

Authors:  Martin Steffl; Markus Schweiger; Judith Mayer; Werner M Amselgruber
Journal:  Histochem Cell Biol       Date:  2009-03-18       Impact factor: 4.304

9.  Role of follicle-stimulating hormone on biliary cyst growth in autosomal dominant polycystic kidney disease.

Authors:  Paolo Onori; Romina Mancinelli; Antonio Franchitto; Guido Carpino; Anastasia Renzi; Stefania Brozzetti; Julie Venter; Heather Francis; Shannon Glaser; Douglas M Jefferson; Gianfranco Alpini; Eugenio Gaudio
Journal:  Liver Int       Date:  2013-04-25       Impact factor: 5.828

10.  Expression of vascular endothelial growth factors and their receptors by hepatic progenitor cells in human liver diseases.

Authors:  Antonio Franchitto; Paolo Onori; Anastasia Renzi; Guido Carpino; Romina Mancinelli; Domenico Alvaro; Eugenio Gaudio
Journal:  Hepatobiliary Surg Nutr       Date:  2013-04       Impact factor: 7.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.